7Rivers Achieves Snowflake Financial Services Industry Competency
MILWAUKEE, May 27, 2025 /PRNewswire/ -- 7Rivers, a Premier Snowflake Services Partner and leader in data and AI consulting, announced that it has achieved the Snowflake Financial Services Industry Competency, a recognition that highlights 7Rivers' proven success delivering innovative, high-impact solutions within the financial services sector using the Snowflake AI Data Cloud.
This competency reflects 7Rivers' deep domain expertise and consistent track record of accelerating digital transformation for banks, insurance companies, capital markets firms, and fintechs. Leveraging its proprietary Data Native™ model and a suite of Snowflake accelerators, 7Rivers helps clients unlock business value through AI-infused applications, predictive analytics, and intelligent experiences.
'Achieving the Snowflake Financial Services Industry Competency is a meaningful milestone for our team and our clients,' said Ben Kerford, President of 7Rivers. 'It reinforces our commitment to helping financial institutions navigate modernization with confidence, transforming data into real-world outcomes that drive growth, mitigate risk, and elevate the customer experience.'
As part of its strategic partnership with Snowflake, 7Rivers empowers financial services organizations to gain greater independence from legacy core providers by simplifying access to their own data. With fewer hurdles to access their data, Banks and Insurance companies are able to more easily and effectively execute on their growth strategies. These include:
As financial institutions grapple with an increasingly complex and escalating risk landscape, economic uncertainty, and an evolving regulatory environment, 7Rivers is actively helping clients stay ahead of the curve. Through our work with leading banks, fintechs, and insurers, we're seeing a surge in focus on:
These capabilities are core to our work helping financial institutions evolve into modern, data-driven, Augmented Enterprises. Our solutions are built not only to solve today's problems, but to position clients for tomorrow's opportunities.
With deep experience in data vault 2.0, AI/ML, and Snowflake-native architecture, 7Rivers is uniquely positioned to help clients become modern, Augmented Enterprises built for agility, powered by data, and guided by innovation.
About 7Rivers
7Rivers' mission is to empower businesses to unlock the transformative potential of data and AI, driving unprecedented success for organizations and their teams. Our mission is to support business leaders in realizing the full potential of their data through cutting-edge data modernization, advanced data science, and state-of-the-art AI solutions.
As a proud Snowflake Premier Partner, we specialize in turning raw data into actionable insights that deliver tangible impact. From establishing an AI-powered data foundation to identifying high-value use cases and deploying Enterprise LLM solutions and Data Native™ applications, 7Rivers is dedicated to guiding organizations through the complexities of today's dynamic landscape and helping them evolve into augmented enterprises.
Discover how 7Rivers can elevate your data strategy and deliver business outcomes at 7riversinc.com.
Contact:
Jessica Emhoff
Vice President, Marketing
7Rivers
[email protected]
www.7riversinc.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/7rivers-achieves-snowflake-financial-services-industry-competency-302464776.html
SOURCE 7Rivers Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
I replaced my fitness instructor with AI. I'm now stronger, more motivated, and saving hundreds of dollars.
I was spending all this money on workout classes and clothes, but wasn't getting any fitter. I already use AI in other areas of my life and decided to try it for my personal fitness. The results have been incredible: I'm stronger, leaner, more motivated, and am saving money too. I used to feel like I needed to spend money to stay in shape — not just on the gym but also on classes, personal training, and enough Lululemon to dress a small Olympic team. I was immersed in a landscape of gymfluencers and self-improvement culture, and that combined with my own poor impulse control, plunged me into a costly cycle where I felt like my ability to stay healthy was increasingly associated with spending. However, I wasn't getting any fitter despite spending over $100 each month on a gym membership, personal training, and workout gear. What finally worked wasn't some militant app that blasted my phone with reminders or a new Apple Watch. It was self-discipline and an AI sidekick. It's been over two months since I replaced my personal trainer with AI, and I've become stronger, leaner, and saved hundreds of dollars, as a result. To be clear, trading people for algorithms wasn't my intention when I started out. After all, it was a person who got me hooked on fitness in the first place. However, I have to admit that using AI to refocus has given me back ownership of my time, money, and motivation. In my early 20s, I traveled frequently between cities, which made it hard for me to establish any consistent habits, including fitness. This lack of structure and haphazard routine came to a head when I moved to Cambridge for a master's program. Juggling full-time work with studies took its toll, and I found that the only real solution to a clean bill of mental health was exercise. I lucked out that one of the instructors running classes at my local gym was brilliant and had a knack for pushing me just beyond my natural limits. I trained with him for about a year, but when he moved on, my motivation tanked. I stayed on at the gym, but wasn't getting what I needed from other instructors and the membership bills kept coming. Testing alternative spaces with Classpass and various free trials at other gyms was fine for a while, but without consistent guidance and encouragement, I started showing up less, making excuses, and procrastinating. All the habit stacking and calendar updates in the world can't help if you just don't want to be somewhere. Bribing myself with new gym wear and post-workout treats helped me show up, but that wasn't sustainable either. The pounds were rolling away, but they were the wrong kind: sterling. I decided to make a change. I already used ChatGPT and Perplexity in other areas of my life — mostly for recipes, travel planning, and other kinds of research and troubleshooting. So, tailoring a personal exercise routine wasn't difficult to start. I used ChatGPT as a master app, entering my goals and progress each week and requesting new or updated workout routines. I also used it to explore issues around willpower and discipline. Where once I might have taken a few days to read and sift out strategies and motivation from books, now I could find solutions in real time and dig into the reasons I might be holding myself back. I even used ChatGPT to find recommendations for other free AI-powered apps. The best of these was Cronometer, a nutrition and calorie-counting app, which I began using daily. I use the free version and it helps me track water intake, macros (carbs, proteins, and fats), fiber, iron, and vitamin levels. I got curious about the results I was seeing with Cronometer and turned to ChatGPT again to learn more about nutrition. I asked it questions like: Why does protein matter so much for muscle growth and recovery? How much do I need? What's the best way to get it? Soon it was providing me with simple meal plans to boost my protein intake and better complement my workouts. I also use a free app that ChatGPT recommended, Hevy, which tracks sets of reps in real time. I also use the free version of Gymmade, which offers a catalog of resistance training exercises with step-by-step instruction and animated illustrations; it's been the perfect tool for confidently handling any free weights. I'm now seeing real results across strength, stamina, body composition, and mood. My muscle definition improved, and I doubled the weight I was lifting in a matter of weeks. Plus, the urge for expensive personal training has vanished. I dropped my gym membership and now I hit my local free outdoor gym instead. I wouldn't have made it to this point without the encouragement of that first brilliant instructor. However, what made the most difference was learning to hold myself accountable and build my own motivation and momentum without anyone's help. I didn't set out to build a DIY fitness routine, but I've stuck to it longer than anything else I've tried on my own. Read the original article on Business Insider
Yahoo
an hour ago
- Yahoo
VNET Group First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Revenue: CN¥2.25b (up 18% from 1Q 2024). Net loss: CN¥237.6m (loss widened by 27% from 1Q 2024). CN¥0.89 loss per share (further deteriorated from CN¥0.71 loss in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) missed analyst estimates. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 11% growth forecast for the IT industry in the US. Performance of the American IT industry. The company's shares are down 11% from a week ago. We should say that we've discovered 3 warning signs for VNET Group (2 can't be ignored!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Business Upturn
an hour ago
- Business Upturn
Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
First-of-its-kind study will use Seer's next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics Seer's new Proteograph ONE Assay to accelerate analysis and reduce costs, making large-scale studies feasible REDWOOD CITY, Calif., June 01, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, and Korea University, a leading research institution committed to innovation and global impact, today announced the launch of a population-level study aimed at identifying novel blood-based biomarkers that could lead to cancer diagnostics for young adults in their 20s and 30s. Relying on Seer's newly launched Proteograph® ONE Assay and SP200 Automation Instrument along with the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer, this is the first large-scale plasma proteomics initiative of its kind to leverage mass spectrometry and AI-driven analytics to enhance early cancer detection and improve patient outcomes. Seer's latest platform advances will allow deep, unbiased proteomic analysis of 20,000 plasma samples in less time and cost than has ever before been possible. These will include samples from 15,000 cancer patients and 5,000 healthy patients that will serve as controls, sourced from Korea's leading cancer institutions: Seoul National University Hospital, the National Cancer Center, and Samsung Medical Center. The three-year study is funded by the K-Health MIRAE initiative under the Ministry of Health and Welfare, Republic of Korea, which supports ambitious, high-impact health research. 'We carefully evaluated multiple approaches to expand the dynamic range of the plasma proteome—including some attempting to replicate Seer's Proteograph platform—and Seer's assay stood out as the only solution capable of delivering the depth, scale, and, critically, reproducibility needed for this ambitious study,' said Professor Sang-Won Lee at the Center of Proteogenome Research (CPGR) of Korea University. 'The unique combination of Seer's latest platform and CPGR's proprietary dual online liquid chromatography technology gives us the ability to conduct population-scale research that would otherwise be prohibitively complex and slow. This collaboration represents a major step toward developing AI-powered diagnostics that could fundamentally improve how we detect and treat cancer in younger adults.' By leveraging the power of deep proteomic analysis, this study aims to catalyze a new wave of diagnostics that are more sensitive, scalable, and personalized—ultimately driving earlier interventions and improving survival outcomes in young adult cancer patients worldwide. Transformational Technology for Population-Scale Proteomics At the heart of the study is Seer's Proteograph ONE workflow, introduced this week at the 2025 American Society for Mass Spectrometry (ASMS) Conference in Baltimore, MD. The next-generation system dramatically increases scale and efficiency in proteomic analysis by: Processing 1,000+ samples per week per instrument Requiring only a single mass spectrometry injection per sample Completing 80-sample batches with <5 hours automated runtime Identifying up to 10 times more proteins than conventional mass spectrometry methods 'Korea University selected Seer's new Proteograph ONE workflow as the foundation for this critical and forward-looking initiative so that they can unlock the full potential of proteomics in population-scale research,' said Omid Farokhzad, Chair and CEO of Seer. 'We're excited to help define a new generation of diagnostics that can transform how diseases like cancer are detected and managed around the world.' The study also employs Thermo Scientific's Orbitrap Astral MS—the industry's leading mass spectrometer for proteomic research. The Proteograph offerings combined with the Orbitrap Astral MS provide a deep, full-range plasma proteome analysis at faster speeds to enable critical breakthrough discoveries in large-population studies. 'When it comes to plasma proteomics studies such as this, the Orbitrap Astral MS and Proteograph ONE workflow provide a powerful solution to drive groundbreaking research,' said Dan Shine, senior vice president and president of analytical instruments, Thermo Fisher Scientific. 'We're proud to be a part of initiatives like this to enable earlier detection and help progress precision medicine.' The next-generation offerings mark a significant evolution of the Proteograph Product Suite, delivering the scale, speed, and efficiency required to make population-level proteomics both practical and accessible. The collaboration with Korea University exemplifies the real-world impact of this technology—demonstrating how deep, unbiased proteomic insights powered by Seer's platform can now inform large-scale studies, accelerate biomarker discovery, and drive the development of AI-enabled diagnostics that redefine precision medicine. About Seer, Inc. Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics—delivering insights with a scale, speed, precision, and reproducibility previously unattainable. Seer's Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer's robust and scalable workflow consistently reveals biological insights that others cannot. Seer's products are for research use only and are not intended for diagnostic procedures. For more information about Seer's differentiated approach and ongoing leadership in proteomics, visit Media Contact: Consort Partners [email protected] Investor Contact: Carrie Mendivil [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
